Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Terminated 2Active not recruiting 2Unknown 1Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 18Neoplasm Metastasis 10Triple Negative Breast Neoplasms 9Lung Neoplasms 9Ovarian Neoplasms 8Carcinoma, Non-Small-Cell Lung 7Breast Neoplasms 7Endometrial Neoplasms 6Fallopian Tube Neoplasms 5Uterine Cervical Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Neoplasms 3Cholangiocarcinoma 3Adenocarcinoma 3Stomach Neoplasms 2Oropharyngeal Neoplasms 2Mouth Neoplasms 2Esophageal Squamous Cell Carcinoma 2Colorectal Neoplasms 2Biliary Tract Neoplasms 2Anatomic Stage I Breast Cancer AJCC v8 2Vulvar Neoplasms 1Vomiting 1Uterine Neoplasms 1Small Cell Lung Carcinoma 1Sinonasal Squamous Cell Carcinoma 1Recurrence 1Pancreatic Ductal Adenocarcinoma (PDAC) 1Pancreatic Cystic Neoplasm 1Pancreatic Adenocarcinoma Metastatic 1

Interventions

Nivolumab 11Oxaliplatin 6Fluorouracil 6Capecitabine 5pembrolizumab 4Paclitaxel 4Leucovorin 4durvalumab 3Radiotherapy 3Folfox protocol 3Drug Therapy 3dehydroftorafur 2Trastuzumab 2Specimen Handling 2Radiation 2Metformin 2Magnetic Resonance Spectroscopy 2Itraconazole 2Irinotecan 2Docetaxel 2Cisplatin 2Carboplatin 2zolbetuximab 1zanidatamab 1trifluridine tipiracil drug combination 1tremelimumab 1trastuzumab deruxtecan 1toripalimab 1tislelizumab 1pertuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Adenocarcinoma Of Esophagus × Taxes × Clear all
NCT06203600 2026-05-26

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

National Cancer Institute (NCI)

Phase 2/3 Recruiting
224 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡